Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data

Overview of attention for article published in Gynecologic Oncology, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 3 X users
patent: 3 patents

guideline: 3 clinical guideline sources

Readers on

mendeley: 163 Mendeley

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 12,150 followers.

$nwbo @alphavestcap @ATLnsider Andrew: Have you written previously on all of Kalinski's ovarian trials , prior to (https://t.co/jZ8zxaPRq8) ? I am looking to compare the components utiized in those trials to those specified for (https://t.co/jZ8zxaP…

$nwbo @alphavestcap https://t.co/kwVG1poQta https://t.co/A3wxFCpQgy

RT @ucl_discovery: Open Access UCL Research: Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carci…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.